Medpace Voice

Medpace has expanded its integrated imaging and specialized assessment capabilities to continue supporting complex Phase I studies. Learn how this approach supports participants and study…

Neurodegenerative clinical trials present unique challenges that extend beyond scientific and operational complexity. Disease progression, caregiver responsibilities, travel burden, complex...

I was attracted to the opportunity to develop clinical skill sets in laboratory medicine while remaining grounded in the laboratory...

The rheumatology landscape continues to evolve as new therapies, technologies, and strategies transform drug development. Many of these advances in...

Retina development continues to be driven by converging scientific, demographic, and commercial forces. With a rapidly growing patient population, and strong investor interest, there is a push for more assets into…

Fulfilling my childhood dream of working in the clinical trial industry. I remember reading a book about clinical trials and...

Discover key insights from the third Alport Research Hub Symposium and learn how Medpace's expertise advances rare nephrology research.

In this Q&A, Lauren Shannon discusses her experience and the role that Medpace plays in advancing innovative rare disease therapies.

After spending 17 years at the University of Cincinnati as a researcher and faculty member, I became interested in applying...

Ophthalmic gene therapy clinical trials aim to correct or replace genes in the eye to slow, halt, or reverse inherited...